Health Care & Life Sciences » Biotechnology | BBI Life Sciences Corp.

BBI Life Sciences Corp. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
62,550.90
59,494.50
70,993.00
82,541.80
82,015.60
103,555.60
Depreciation, Depletion & Amortization
14,019.00
16,436.40
20,070.00
22,004.80
28,282.90
34,488.90
Other Funds
1,660.40
31,492.20
-
-
-
10,168.50
Funds from Operations
60,340.40
54,606.30
93,592.80
84,413.60
93,767.90
127,876
Changes in Working Capital
18,065.30
20,666.30
17,901.50
13,684.50
9,813.90
11,875.30
Net Operating Cash Flow
78,405.70
75,272.60
111,494.30
98,098.10
103,581.80
139,751.30
Capital Expenditures
19,168.00
23,870.50
71,971.10
150,620.80
188,412.10
Sale of Fixed Assets & Businesses
709.10
1,593.30
13.60
3,484.20
9,756.30
Purchase/Sale of Investments
-
23,996.40
11,645.30
64,346.00
2,461.80
Net Investing Cash Flow
2,177.70
4,216.10
65,037.70
230,985.80
185,364.50
Cash Dividends Paid - Total
-
-
4,084.10
5,973.00
6,583.00
Issuance/Reduction of Debt, Net
13,878.90
-
-
-
7,665.70
Net Financing Cash Flow
12,218.50
28,720.90
137,694.70
2,339.20
2,529.90
Net Change in Cash
68,520.10
108,567.00
190,043.60
121,562.30
82,791.60
Free Cash Flow
60,459.00
54,815.30
41,985.20
52,504.10
84,507.40
Net Assets from Acquisitions
-
-
4,725.50
11,771.80
4,246.80
Other Sources
21,911.00
2,496.90
-
-
-
Change in Capital Stock
-
60,213.10
141,778.70
8,312.10
1,447.10
Exchange Rate Effect
155.20
357.40
5,892.30
8,986.30
3,538.80
Other Uses
1,274.30
-
-
7,731.40
-

About BBI Life Sciences

View Profile
Address
No. 698, Xiangmin Road
Shanghai Shanghai 201611
China
Employees -
Website http://www.bbi-lifesciences.com
Updated 07/08/2019
BBI Life Sciences Corp. is an investment holding company that engages in the development, manufacture, and sale of various life sciences products used in scientific research. The firm also provides life sciences related services. It operates through the following segments: DNA Synthesis Products, Genetic Engineering Services, Life Sciences Research Consumables, and Protein and Antibody Related Products and Services.